What do we do:
Dra. Mercè Boada, Medical director
"There are many factors involved in making the diagnosis a diagnosis of excellence. At Fundació ACE we aim to generate synergies among all research programs to guarantee the maximum possible scope of our research."GScholar
- detect when and how the disease begins to act,
- and study the course that follows depending on different aspects.
FACEHBI - Fundació ACE Healthy Brain Initiative
Fundació ACE, Hospital Clínic de Barcelona, Clínica Corachan, Grifols, Piramal & Araclon Biotech
FACEHBI is a research project that aims to study the subjective memory complaints of 200 people without cognitive impairment, despite they notice memory loss.
MOPEAD - Models of Patient Engagement for Alzheimer's Disease
European Comission (H2020-JTI-IMI2-2015-05)
The MOPEAD project is a European initiative that aims to give citizens an active role in the early detection of Alzheimer's. For this reason, it studies the effectiveness of different participatory mechanisms.
BIOFACE - Study of Biomarkers in early cognitive mild cognitive impairment at Fundació ACE
Instituto de Salud Carlos III
The BIOFACE project that analyzes different biomarkers (neuroimaging, genetic and biochemical) in order to assess whether these can be a useful diagnostic tool for mild cognitive impairment in people under 65 years old.
NORFACE - Neuro-ophthalmology Research at Fundació ACE
Fundació Castell de Peralada, Fundació ACE, Topcon, European Comission (Marie Skłodowska-Curie Actions)
NORFACE is a project that studies the relation between cognitive impairment and the thickness of the retina in people with Alzheimer's, by using an Optical Coherence Tomography (OCT), a non-invasive technique that takes a photograph of the eye.